Nigel S B Rawson (Nigel Sb Rawson)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Topics

Coronavirus Disease

Tyrosine Kinase

Psychometric Properties

Lymph Node Metastasis

Top Venues

Current oncology (Toronto, Ont.)

Journal of comparative effectiveness research

ClinicoEconomics and outcomes research : CEOR

International journal of health policy and management

This page only lists publications with an associated author ORCID identifier.

Publications

Chakrapani Balijepalli, Lakshmi Gullapalli, Juhi Joshy, Nigel S B Rawson
The impact of willingness-to-pay threshold on price reduction recommendations for oncology drugs: a review of assessments conducted by the Canadian Agency for Drugs and Technologies in Health. Journal of comparative effectiveness research 13 (5) (2024)
David J Stewart, John-Peter Bradford, Sandeep R Sehdev, Tim Ramsay, Vishal Navani, Nigel S B Rawson, Di Maria Jiang, Joanna Gotfrit, Paul Wheatley-Price, Geoffrey Liu, Alan G Kaplan, Silvana Spadafora, Shaun G Goodman, Rebecca A C Auer, Gerald Batist
New Anticancer Drugs: Reliably Assessing "Value" While Addressing High Prices. Current oncology (Toronto, Ont.) 31 (5) (2024)
Chakrapani Balijepalli, Lakshmi Gullapalli, Juhi Joshy, Nigel S B Rawson
The impact of willingness-to-pay threshold on price reduction recommendations for oncology drugs: a review of assessments conducted by the Canadian Agency for Drugs and Technologies in Health. Journal of comparative effectiveness research 13 (5) (2024)
Chakrapani Balijepalli, Lakshmi Gullapalli, Juhi Joshy, Nigel S B Rawson
The impact of willingness-to-pay threshold on price reduction recommendations for oncology drugs: a review of assessments conducted by the Canadian Agency for Drugs and Technologies in Health. Journal of comparative effectiveness research 13 (5) (2024)
Sandeep R Sehdev, Nigel S B Rawson, Olexiy I Aseyev, Catriona J Buick, Marcus O Butler, Scott Edwards, Sharlene Gill, Joanna M Gotfrit, Cyrus C Hsia, Rosalyn A Juergens, Mita Manna, Joy S McCarthy, Som D Mukherjee, Stephanie L Snow, Silvana Spadafora, David J Stewart, Jason R Wentzell, Ralph P W Wong, Pawel G Zalewski
Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement. Current oncology (Toronto, Ont.) 31 (4) (2024)
Chakrapani Balijepalli, Lakshmi Gullapalli, Juhi Joshy, Nigel S B Rawson
The impact of willingness-to-pay threshold on price reduction recommendations for oncology drugs: a review of assessments conducted by the Canadian Agency for Drugs and Technologies in Health. Journal of comparative effectiveness research 13 (5) (2024)
David J Stewart, John-Peter Bradford, Sandeep R Sehdev, Tim Ramsay, Vishal Navani, Nigel S B Rawson, Di Maria Jiang, Joanna Gotfrit, Paul Wheatley-Price, Geoffrey Liu, Alan G Kaplan, Silvana Spadafora, Shaun G Goodman, Rebecca A C Auer, Gerald Batist
New Anticancer Drugs: Reliably Assessing "Value" While Addressing High Prices. Current oncology (Toronto, Ont.) 31 (5) (2024)
David J Stewart, John-Peter Bradford, Sandeep R Sehdev, Tim Ramsay, Vishal Navani, Nigel S B Rawson, Di Maria Jiang, Joanna Gotfrit, Paul Wheatley-Price, Geoffrey Liu, Alan G Kaplan, Silvana Spadafora, Shaun G Goodman, Rebecca A C Auer, Gerald Batist
New Anticancer Drugs: Reliably Assessing "Value" While Addressing High Prices. Current oncology (Toronto, Ont.) 31 (5) (2024)
Sandeep R Sehdev, Nigel S B Rawson, Olexiy I Aseyev, Catriona J Buick, Marcus O Butler, Scott Edwards, Sharlene Gill, Joanna M Gotfrit, Cyrus C Hsia, Rosalyn A Juergens, Mita Manna, Joy S McCarthy, Som D Mukherjee, Stephanie L Snow, Silvana Spadafora, David J Stewart, Jason R Wentzell, Ralph P W Wong, Pawel G Zalewski
Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement. Current oncology (Toronto, Ont.) 31 (4) (2024)
Sandeep R Sehdev, Nigel S B Rawson, Olexiy I Aseyev, Catriona J Buick, Marcus O Butler, Scott Edwards, Sharlene Gill, Joanna M Gotfrit, Cyrus C Hsia, Rosalyn A Juergens, Mita Manna, Joy S McCarthy, Som D Mukherjee, Stephanie L Snow, Silvana Spadafora, David J Stewart, Jason R Wentzell, Ralph P W Wong, Pawel G Zalewski
Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement. Current oncology (Toronto, Ont.) 31 (4) (2024)
Chakrapani Balijepalli, Lakshmi Gullapalli, Juhi Joshy, Nigel S B Rawson
The impact of willingness-to-pay threshold on price reduction recommendations for oncology drugs: a review of assessments conducted by the Canadian Agency for Drugs and Technologies in Health. Journal of comparative effectiveness research (2024)
Chakrapani Balijepalli, Lakshmi Gullapalli, Juhi Joshy, Nigel S B Rawson
The impact of willingness-to-pay threshold on price reduction recommendations for oncology drugs: a review of assessments conducted by the Canadian Agency for Drugs and Technologies in Health. Journal of comparative effectiveness research 13 (5) (2024)
Nigel S B Rawson, David J Stewart
Timeliness of Health Technology Assessments and Price Negotiations for Oncology Drugs in Canada. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Sandeep R Sehdev, Nigel S B Rawson, Olexiy I Aseyev, Catriona J Buick, Marcus O Butler, Scott Edwards, Sharlene Gill, Joanna M Gotfrit, Cyrus C Hsia, Rosalyn A Juergens, Mita Manna, Joy S McCarthy, Som D Mukherjee, Stephanie L Snow, Silvana Spadafora, David J Stewart, Jason R Wentzell, Ralph P W Wong, Pawel G Zalewski
Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement. Current oncology (Toronto, Ont.) 31 (4) (2024)
Nigel S B Rawson, David J Stewart
Timeliness of Health Technology Assessments and Price Negotiations for Oncology Drugs in Canada. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Nigel S B Rawson
Health technology assessment and price negotiation alignment for rare disorder drugs in Canada: Who benefits? Orphanet journal of rare diseases 17 (1) (2022)
Nigel S B Rawson, John Adams
Prioritisation for therapies based on a disorder's severity: ethics and practicality. Journal of medical ethics 48 (2) (2022)
Nigel S B Rawson
National Pharmacare in Canada: Equality or Equity, Accessibility or Affordability Comment on "Universal Pharmacare in Canada: A Prescription for Equity in Healthcare". International journal of health policy and management 9 (12) (2020)
Nigel S B Rawson, Carl D'Arcy
Healthcare Databases for Drug Safety Research: Data Validity Assessment Remains Crucial. Drug safety 41 (9) (2018)
Nigel S B Rawson
Promoting adherence to medicines: possible lessons for Canada? Israel journal of health policy research 6 (1) (2017)